Laquinimod, an upcoming oral immunomodulatory agent for treatment of multiple sclerosis. Varrin-Doyer M, Zamvil SS, Schulze-Topphoff U Exp Neurol. 2014 Apr 13. PMID: 24731945. Abstract CommentRecommendBookmarkWatch